A USC-led study published in Lung Cancer compared five leading ALK+ lung cancertherapiesoutsideclinical trials,finding that optimaltreatment variesbypatientcharacteristics.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions
Compared Head-To-Head 5 leading ALK+ lung cancer drugs
By Patient Characteristics Optimaltreatment varies